TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Endothelial cell count using specular microscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with Dose limiting toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of Life Inventory for Children (PedsQL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Memorial Symptom Assessment Scale (7-12 years old)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fatigue Assessment Scale for Pediatric Oncology Patients Aged 7-12
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Circumference of knees and lower extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Total time for intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Measurement of sulfonic acid and HRP flux
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression levels of key inflammation cytokines (TNFα, IL 1β, IFNɣ...)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of serotonin-producing cells labelled with anti-5-HT antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Amplitude degree of lower limbs articulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamics of limbs joint torques during walking initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Solicited Injection-site Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Detection of urinary sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Inflammation in rheumatoid arthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Shoulder joint range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: I-RODS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Safety of 4SCAR19U CAR-T cells infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Hospital stay after surgery
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Bone Mineral Density (BMD) - Hip and Spinal (L1-L4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor alignment in primary position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived involvement in decision-making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decision-making experiences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Family adaptability and cohesion
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Coping behaviors in response to illness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Minor's anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptance of study participation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in procedural performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety while positioning on the fluoroscopy table
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety when local anesthetic is injected
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety when the epidural needle is removed
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effectiveness of cueing interventions at one month postpartum
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness of cueing interventions at three months postpartum
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness of cueing interventions at six months postpartum
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Peak Genioglossus Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tensor Palatini Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Self-Care Behaviors Scale in Endometriosis
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Endometriosis Health Profile
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Children's Depressing Rating Scale-Revised
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reynolds Adolescent Depression Scale-2 (RADS-2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS-PL)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Different-day, Different-operator Reproducibility Coefficient of Shear Wave Speed Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Financial Distress
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Cervical histopathology testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Human Papillomavirus (HPV) viral integration test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cervical cytology testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Adherence to the anti-inflammatory diet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Offspring body composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal cardiometabolic profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Sunburn Occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: cumulated oral morphine equivalent (OME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with modified Rankin Scale (mRS) Score 0-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of drugs of abuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance assessment (Eyes closed standing on firm surface)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional mobility (5 Times sit to stand test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Step down ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver Dosing Error
Endpoint domain: Adverse events/effects
Primary endpoint: Caregiver Large Dosing Error
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacy Use of mL-only on Rx Label
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pharmacy Provision of Optimal Dosing Tool
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in fatigue perception
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Area Under the Curve From 0 to the Time of the Last Quantifiable Concentration (AUC(0-t))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulse rate before and after gastroscopy procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Respiratory rate before and after gastroscopy procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Systolic and diastolic blood pressure before and after gastroscopy procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxygen saturation values before and after gastroscopy procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cervical Joint Range of Motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Craniocervical Angle (CVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum isometric muscle force of flexion of the MTP joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: prevalence of HDV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of participants with detectable HDV RNA among seropositive anti HDV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: predictive risk of HDV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to COVID-19 Symptom Alleviation by Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Experiencing Serious Adverse Events (SAEs) and Adverse Events (AEs) Leading to Study Drug Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Technical success of gastroscopes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Opioid consumption (in Morphine Milligram Equivalents)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional capacity measured by ADL-Glittre test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: placebo-corrected dQTcF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Hypersexual Behavior Inventory (HBI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number and effector function of epidermal CD8+CD103+ Trm cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in self-management of JIA
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in pain-management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vancomycin use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: In vivo contractility of the human thoracic aorta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Energy Purchased
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Cost of Groceries
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Success of treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Vaccination-induced T-cell response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from functional impairment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Psychosocial health and wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to first supplemental aflibercept injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Responder rate of the PRF group and Sham-Control group
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of adverse events (AEs) and serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Nerve Conduction Velocity 14th day compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total Amount of Opioid Medications Administered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence to Therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants with remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol Flushing Awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Alcohol Consumption Habits 1
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Alcohol Consumption Habits 2
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Alcohol Consumption Habits 3
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Alcohol Consumption Habits 4
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of mechanical complications
Endpoint domain: Adverse events/effects
Primary endpoint: Score for surgical competence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Functionality - WOMAC survey
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Post Liver Transplant bacterial infection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Acute postoperative pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity 6 months postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial infarction or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Change in Sugaya score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic vascular graft or endograft infection
Endpoint domain: Adverse events/effects
Primary endpoint: Child Anxiety Scale-State
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety - immediate
Endpoint domain: Adverse events/effects
Primary endpoint: Safety - post scan
Endpoint domain: Adverse events/effects
Primary endpoint: Safety - delayed
Endpoint domain: Adverse events/effects
Primary endpoint: PRO-BNP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vital signs - systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Freedom from major adverse cardiac events (MACE)
Endpoint domain: Mortality/survival
Primary endpoint: Mean absolute difference (MAD) value between Bio-Z wristband and Finapres Nova®
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose (MTD) and/or the recommended phase 2 dosage (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in fasting blood glucose (mg/dL) at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in blood lipid parameters (mg/dL) at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in BMI (kg/m2) at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life Enjoyment and Satisfaction Questionnaire (Short Form)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Tolerability of [18F]BL40
Endpoint domain: Adverse events/effects
Primary endpoint: Absorbed doses (ADs) to normal organs and tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with tumors shown by [18F]BL40 PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: somatosensory evoked potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Range of Motion (ROM) of the Joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EUS-E accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ovarian specific overall survival
Endpoint domain: Mortality/survival
Primary endpoint: PPR change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPR change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of dextromethorphan and its dextrorphan metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of IV midazolam and its 1'-hydroxymidazolam metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who will die from bladder cancer
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants who will experience bladder cancer recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants who will die from all causes
Endpoint domain: Mortality/survival
Primary endpoint: Composite Metabolic Syndrome Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of adverse events/serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of no art-line EVAR
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Technical feasibility of no art-line EVAR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Safety of no art-line EVAR
Endpoint domain: Adverse events/effects
Primary endpoint: consent rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: resources
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in beta-cell responsivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Serum concentrations of Dexmedetomidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of oral proglumide therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Physician-assessed ED disposition (likelihood of admission)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient final disposition (admitted/discharged)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term safety of TEGSEDI
Endpoint domain: Adverse events/effects
Primary endpoint: Success aneurysm occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Completion of Oxford Knee Score (OKS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of patients with tidal volume in optimal, suboptimal, unoptimal zone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Global Aesthetic Improvement scale (GAI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hypotension Prediction Index (HPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: dP/dt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of karyotypically normal blastocysts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change from Baseline in the 10-Meter Walk Test (10MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of study subjects reporting adverse events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: GMT of the serum SARS-CoV-2 binding antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of subjects with four folds increase in serum SARS-CoV-2 binding antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence and severity of radiation induced oral mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICM-detected ATA burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent agreement with pilot sensor and current standard
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with DLT
Endpoint domain: Adverse events/effects
Primary endpoint: Change in perceived loneliness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants Who Quit Smokeless Tobacco Measured by Self Report
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of relapse from baseline to 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response free survival
Endpoint domain: Mortality/survival
Primary endpoint: Grade dysfunction of lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of low-grade inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distribution of wall shear stress in the aorta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Red Blood Cell (RBC) transfusion units received
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Participant hemoglobin (Hb) level results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Participant serum ferritin results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall response rate (ORR) after GZL therapy
Endpoint domain: Mortality/survival
Primary endpoint: Complete response rate (CRR) after CAR-T
Endpoint domain: Mortality/survival
Primary endpoint: Progression-free survival (PFS) after CAR-T
Endpoint domain: Mortality/survival
Primary endpoint: Mean monocular best-corrected distance visual acuity (CDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in patient-reported pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Host transcriptional signatures for active TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes